|
Vero-TMUV cells
|
0.564 mM
|
Dose-response assay; Gluc activity examination; CellTiter-Glo® Luminescent Cell Viability Assay
|
PMC12719727
|
|
NCCIT-R
|
5 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
2102Ep-R
|
2 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
NT2-R
|
17 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
NCCIT-P
|
6 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
2102Ep-P
|
6 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
NT2-P
|
3 nM
|
Resazurin viability assay; spectrophotometric measurement at 560 nm (reference wavelength: 600 nm); IC50 values extrapolated from sigmoidal dose-response (four-parametric logistic equation) with a variable slope on GraphPad Prism 6.
|
Download PDF
|
|
Huh7
|
19.9 nM
|
CCK-8 assay
|
Download PDF
|
|
Hep3B
|
74.8 nM
|
CCK-8 assay
|
Download PDF
|
|
P. falciparum 3D7
|
10 nM
|
[3H]-hypoxanthine incorporation assay followed by liquid scintillation counting.
|
PMC7724001
|
|
MMQ
|
0.0615 μM
|
CellTiter 286 Aqueous One Solution assay
|
Download PDF
|
|
GH3
|
0.09575 μM
|
CellTiter 286 Aqueous One Solution assay
|
Download PDF
|
|
IMR-32
|
7.5 ± 0.1 nM (24h), 3.5 ± 0.5 nM (48h), 2.1 ± 0.5 nM (72h)
|
XTT assays
|
Download PDF
|
|
HEK293
|
>1000 nM (24h), 509.0 ± 83.8 nM (48h), 107.0 ± 40.1 nM (72h)
|
XTT assays
|
Download PDF
|
|
IMR-32
|
4.9 ± 0.7 nM (24h), 2.7 ± 0.5 nM (48h), 2.5 ± 0.9 nM (72h)
|
XTT assays
|
Download PDF
|
|
HEK293
|
>1000 nM (24h), 40.5 ± 12.8 nM (48h), 38.5 ± 7.8 nM (72h)
|
XTT assays
|
Download PDF
|
|
Human kidney fibroblasts
|
>1000 nM (24h), 120.3 ± 44.3 nM (48h), 35.5 ± 19.8 nM (72h)
|
XTT assay
|
Download PDF
|
|
Human kidney fibroblasts
|
>1000 nM (24h), 328.2 ± 98.5 nM (48h), 158.9 ± 40.5 nM (72h)
|
XTT assay
|
Download PDF
|
|
HCT8 cells
|
130 µM
|
[Vendor] CellTiter Aqueous One Solution Cell Proliferation Assay (MTS) for TC50 measurement
|
Download PDF
|
|
CT26 cells
|
300 nM
|
ELISA and CCK-8 assay
|
PMC11648303
|
|
CLBL-1
|
18.32±0.024nM
|
Alamar Blue cell viability assay, calculated using GraphPad Prism software (version 9.2.0, San Diego, CA, USA) using response vs. log (inhibitor) function with variable slope.
|
Download PDF
|
|
T. gondii tachyzoites (RH strain) in RPE cells
|
424.41 ± 48.07 nM
|
Proliferation observed by inverted fluorescence microscope and Giemsa staining
|
Download PDF
|
|
A204
|
8 nM
|
live cell imaging (IncuCyte ZOOM®)
|
Download PDF
|
|
VAESBJ
|
26 nM
|
live cell imaging (IncuCyte ZOOM®)
|
Download PDF
|
|
GRU1
|
16 nM
|
live cell imaging (IncuCyte ZOOM®)
|
Download PDF
|
|
MOSC-GR-001-ES
|
77 nM
|
live cell imaging (IncuCyte ZOOM®)
|
Download PDF
|
|
NIDIS cells
|
0.5μM
|
USm activity assay and cell viability assay
|
Download PDF
|
|
Vero cells
|
0.5μM
|
USm activity assay and cell viability assay
|
Download PDF
|
|
HCC1937
|
231.6 nM
|
MTT assays
|
Download PDF
|
|
A-172
|
11.47 nM
|
MTT assays
|
Download PDF
|
|
LN-18
|
15.6 nM
|
MTT assays
|
Download PDF
|
|
acute myeloid leukemia cell line
|
-5.600 (log IC50)
|
DepMap dataset (IC50(log) values)
|
Download PDF
|
|
BT245 cells
|
16.1 nM
|
MTS [3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay
|
PMC10547466
|
|
KPC3 cells
|
0.11 µM
|
Cell proliferation assay by total DNA measurement using bisbenzimide fluorescent dye (Hoechst 33258).
|
Download PDF
|
|
HKBML
|
12.2 nM
|
assay
|
Download PDF
|
|
TL-1
|
4.6 nM
|
assay
|
Download PDF
|
|
TK
|
11.6 nM
|
assay
|
Download PDF
|
|
SL00755
|
109.7 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01287
|
70.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01258
|
34.69 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01251
|
50.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01306
|
40.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01307
|
30.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01308
|
20.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01309
|
10.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
SL01310
|
10.01 nM
|
Luminescent Cell Viability Assay, GraphPad Prism
|
Download PDF
|
|
BT-549
|
15.0μM
|
4-parameter log-logistic growth curves estimated using the drc R package
|
Download PDF
|
|
GUMC-403
|
2.600 uM
|
reagent luminescence signal read using a ViewLux ([Vendor])
|
Download PDF
|
|
GUMC-403
|
0.035 uM
|
CellTiter-Glo® Luminescent Cell Viability Assay
|
Download PDF
|
|
GUMC-403
|
0.030 uM
|
CellTiter-Glo® 3D Cell Viability Assay
|
Download PDF
|
|
K562
|
61.31 nmol/L
|
MTT assay
|
Download PDF
|
|
F98
|
0.18 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
U87-MG
|
0.19 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
M059K
|
0.17 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
F98
|
0.2 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
U87-MG
|
0.2 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
M059K
|
0.18 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
G144
|
0.18 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
G26
|
0.19 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
G144
|
0.18 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
G26
|
0.19 µg/mL
|
Two-color fluorescent-based live/dead cell viability assay, logarithmic dose–response curves.
|
Download PDF
|
|
MDA-MB468
|
100 nM
|
Growth inhibition determined by MTT assay
|
Download PDF
|
|
GBM1A
|
482 nmol/L
|
MTS assay
|
Download PDF
|
|
PEER
|
~150 nM
|
MTT assay
|
Download PDF
|
|
OVCAR8
|
7.5 nM
|
MTT assay
|
Download PDF
|
|
OVCAR8-TR
|
around 7.5 nM
|
MTT assay
|
Download PDF
|
|
SKOV3
|
25 nM
|
MTT assay
|
Download PDF
|
|
SKOV3-TR
|
100 nM
|
MTT assay
|
Download PDF
|
|
HSJD-DIPG-007
|
15.3 nM
|
MTS assay
|
Download PDF
|
|
HSJD-DIPG-008
|
28.3 nM
|
MTS assay
|
Download PDF
|
|
HSJD-DIPG-011
|
12.1 nM
|
MTS assay
|
Download PDF
|
|
HSJD-DIPG-012
|
26.8 nM
|
MTS assay
|
Download PDF
|
|
HSJD-GBM-001
|
18.0 nM
|
MTS assay
|
Download PDF
|
|
HCC827
|
10 nM
|
WST-1 assay, cell growth inhibited to 50% of DMSO control.
|
Download PDF
|
|
A549
|
20 nM
|
WST-1 assay, cell growth inhibited to 50% of DMSO control.
|
Download PDF
|
|
NCI-H460
|
35 nM
|
WST-1 assay, cell growth inhibited to 50% of DMSO control.
|
Download PDF
|
|
FRO pLKO.1
|
1000 nM
|
MTS assay
|
Download PDF
|
|
FRO shHMGA1
|
100 nM
|
MTS assay
|
Download PDF
|
|
SK-NEP-1
|
76.34 nM
|
CCK-8 assay, Graph Prism software
|
Download PDF
|
|
G401
|
143.02 nM
|
CCK-8 assay, Graph Prism software
|
Download PDF
|
|
HMCLs with high HA Score
|
1.16 nM
|
Cell Titer Glo Luminescent Assay ([Vendor]); IC50 determined using [Vendor] Prism
|
PMC3739014
|
|
HMCLs with low HA Score
|
3.16 nM
|
Cell Titer Glo Luminescent Assay ([Vendor]); IC50 determined using [Vendor] Prism
|
PMC3739014
|
|
GIST cell lines
|
80-100 nM
|
Growth inhibition assay
|
PMC3950855
|
|
H23
|
14 nM to 30 nM
|
AlamarBlue® assay
|
Download PDF
|
|
A549
|
14 nM to 30 nM
|
AlamarBlue® assay
|
Download PDF
|
|
LNCaP
|
0.05 ± 0.02 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
PC3
|
0.1 ± 0.05 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
DU145
|
0.05 ± 0.014 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
RPMI8226
|
0.036 ± 0.005 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
KMS12BM
|
0.2 ± 0.01 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
KMS21BM
|
0.031 ± 0.05 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|
|
DU145R80
|
0.071 ± 0.023 µM
|
sulforhodamine B (SRB) or MTT (3-(4,5-dimethylthiazolyl-2)-2,5-diphenyl tetrazolium bromide) assay
|
PMC3920938
|